They further proved that SAH probes could enrich MT-associated proteins and be used to screen for and to assess the selectivity of MT inhibitors, which led to the discovery of a covalent inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cancer and metabolic disorders. This evidence concerns the gene MCAT and metabolic disease.